Skip to main content

Pacific Edge Health Care
Cancer Healthcare Medical New Zealand

$0.077 -0.003 (-3.75%)

High

$0.08

Low

$0.08

Trades

6

Turnover

$17,007

Volume

211,355
30 June 2023 at 1:01pm
If you were already registered, log in here.
PEB Announcements on Price Chart

Latest Announcements

Headline Date
Notice of Annual General Meeting/Proxy Form 26 June 2023 at 2:40pm
Annual Report to shareholders 22 June 2023 at 8:10am
Medicare Coverage of Cxbladder Expected to Cease 7 June 2023 at 9:00am
Pacific Edge Trading Halt 6 June 2023 at 11:30am
Trading Halt 5 June 2023 at 9:20am
Clarification of Novitas Timeline 2 June 2023 at 8:05am
Pacific Edge Delivers on Growth Strategy in FY 2023 25 May 2023 at 8:50am
Director Nomination Closing Date 22 May 2023 at 2:10pm
Notification regarding unquoted securities - PEB 3 May 2023 at 11:20am
Capital Change Notice - NZX 3 May 2023 at 11:20am
Pacific Edge Full Year Result to be Announced 25 May 2023 1 May 2023 at 11:45am
Quarterly Update Q4 23 Test Volumes Reach New Record 18 April 2023 at 8:00am
Pacific Edge Provides Update on Kaiser EMR Integration 31 March 2023 at 8:00am
Quarterly Investor Update - Q3 FY23 Test Volumes rise 36% 19 January 2023 at 8:10am
Te Whatu Ora - Southern Commercial Agreement Completed 13 January 2023 at 8:25am
Notification regarding unquoted securities - PEB 22 December 2022 at 8:15am
Application for quotation of securities - PEB 21 December 2022 at 3:10pm
Notification of cessation of securities - PEB 21 December 2022 at 12:20pm
NZX D&O Disclosures - P Meintjes & G Gibson 21 December 2022 at 11:35am
Capital Change Notice - NXZ 21 December 2022 at 11:35am
Capital Change Notice - NZX 21 December 2022 at 11:35am
Enhanced Cxb Tests Deliver Improved Diagnostic Performance 13 December 2022 at 8:00am
Financial Results for the Half Year to 30 September 2022 24 November 2022 at 8:05am
Interim Financial Results to be Announced 24 November 2022 11 November 2022 at 8:00am
Quarterly Investor Update - Q2 FY23 Test Volumes rise 36% 17 October 2022 at 8:00am
Letter to Shareholders 17 October 2022 at 8:00am
Update on Te Whatu Ora Southern Commercial Agreement 23 September 2022 at 8:05am
PACIFIC EDGE COMMENTS ON PROPOSED NOVITAS LCD 1 August 2022 at 9:00am
Trading Halt 29 July 2022 at 10:40am
Pause in Trading 29 July 2022 at 10:20am
Pacific Edge 2022 Annual Shareholders Meeting - Results 29 July 2022 at 8:05am
Pacific Edge 2022 Annual Shareholders Meeting 28 July 2022 at 1:30pm
Pacific Edge Appoints Chief Operating Officer 28 July 2022 at 8:05am
Southern District Health Region Adopts Cxbladder Tests 21 July 2022 at 8:05am
Pacific Edge Investor Update - Q1 FY23 Test Volumes Rise 32% 20 July 2022 at 8:05am
Notice of Annual General Meeting/Proxy Form 22 June 2022 at 1:10pm
Annual Report to shareholders 22 June 2022 at 8:20am
Kaiser Permanente agrees to Cxbladder EMR Integration 1 June 2022 at 2:45pm
Pacific Edge LTD FY22 Result 26 May 2022 at 9:45am
PEB FY22 Result - NZX Announcement Template 26 May 2022 at 9:45am
Director Nomination Closing Date 23 May 2022 at 1:40pm
Clinical Study Advancing Cxbladder as standard of care 10 May 2022 at 8:55am
Pacific Edge Full Year Result to be Announced 26 May 2022 3 May 2022 at 10:40am
D&O Disclosure - NZX - D Darling 28 April 2022 at 1:15pm
Capital Change Notice - NZX 26 April 2022 at 1:25pm
Application for quotation of securities - PEB 26 April 2022 at 1:25pm
PEB Investor Update - March 2022 30 March 2022 at 10:45am
Pacific Edge Appoints Tony Barclay to its Board 17 March 2022 at 8:00am
Application for quotation of securities - PEB 3 March 2022 at 12:45pm
Application for quotation of securities - PEB 3 March 2022 at 12:35pm
If you were already registered, log in here.